World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
51723
World Ranking
8435
National Ranking
825

Overview

Chris Parker is affiliated with the Institute of Cancer Research in the United Kingdom and has contributed extensively to the field of medicine, with a total of 132 publications. Their research primarily spans several subfields including pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, surgery, cancer research, and oncology.

The main focus of their work lies in prostate cancer, particularly in treatment and research as well as diagnosis and treatment strategies. Additional topics cover radiopharmaceutical chemistry and applications, advanced radiotherapy techniques, cancer metabolism related to lipids, treatments for bladder and urothelial cancer, and the application of radiomics and machine learning in medical imaging.

Chris Parker has published multiple papers in prominent journals. Notable recent publications include:

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020), Annals of Oncology
  • Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial (2022), PLoS Medicine

Frequent coauthors collaborating with Chris Parker include Matthew R. Sydes, Noel W. Clarke, Nicholas D. James, William Cross, and Mahesh Parmar, reflecting ongoing research partnerships across numerous highly cited studies.

Key venues where Parker's work has been published often include:

  • Annals of Oncology
  • European Urology
  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • JNCI Cancer Spectrum

Best Publications

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

    Hashim U Ahmed;Hashim U Ahmed;Ahmed El-Shater Bosaily;Ahmed El-Shater Bosaily;Louise C. Brown;Rhian Gabe

  • Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

    Johann S. de Bono;Howard I. Scher;R. Bruce Montgomery;Christopher Parker

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  • Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    David Dearnaley;Isabel Syndikus;Helen Mossop;Vincent Khoo

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

    Gerhardt Attard;Alison H.M. Reid;Timothy A. Yap;Florence Raynaud

  • Multiple newly identified loci associated with prostate cancer susceptibility.

    Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama

  • Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

    Gerhardt Attard;Alison H.M. Reid;Roger A'Hern;Christopher Parker

  • Active Surveillance for Prostate Cancer: A Systematic Review of the Literature

    Marc A. Dall’Era;Peter C. Albertsen;Christopher Bangma;Peter R. Carroll

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.: Annals of oncology : official journal of the European Society for Medical Oncology

    C. Parker;E. Castro;K. Fizazi;A. Heidenreich

  • Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer

    Gerhardt Attard;Joost F. Swennenhuis;David Olmos;Alison H.M. Reid

  • Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

    Sten Nilsson;Lars Franzén;Christopher Parker;Christopher Tyrrell

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Prevention and early detection of prostate cancer

    Jack Cuzick;Mangesh A Thorat;Gerald L Andriole;Otis W Brawley;Otis W Brawley

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    A. Horwich;C. Parker;Chris Bangma;Vesa Kataja

  • Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

    Alison H.M. Reid;Gerhardt Attard;Daniel C. Danila;Nikhil Babu Oommen

Frequent Co-Authors

David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Robert Huddart
Robert Huddart Institute of Cancer Research
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Nicholas D. James
Nicholas D. James Institute of Cancer Research
Gerhardt Attard
Gerhardt Attard University College London
Matthew R. Sydes
Matthew R. Sydes University College London
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
Oliver Sartor
Oliver Sartor Tulane University
Noel W. Clarke
Noel W. Clarke University of Salford
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn’t always mean following the traditional path to becoming a doctor. There are many medical billing and coding certification cost options that make it easier and more affordable for students to step into the healthcare field. These certifications can be completed online, providing a flexible entry point for those interested in healthcare administration.

For students who are passionate about patient care, affordable nursing programs online can help reduce education expenses while offering comprehensive training. As the demand for advanced nursing professionals grows, many are seeking the cheapest online nurse practitioner programs to earn specialized credentials and increase their career opportunities.

Those looking to reach the highest academic levels in nursing can consider online nursing doctoral programs. These programs allow working professionals to continue their education with minimal disruption and prepare for leadership roles in research, education, or advanced practice.

Best Scientists Citing Chris Parker

Trending Scientists

Recently Published Articles